Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 206
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First Look at Gilgamesh’s Phase 2a Data; ASCP 2025 Preview; VA Sec. Pressed on...
EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic Access for Veterans
Ibogaine – The Promise, the Protocol, and Protecting the Sacred
Pα+ Psychedelic Bulletin #195: Psychedelics Namechecked in Trump Cabinet Meeting; Noma Therapy Aims to Disrupt At-Home Ketamine; Christian Angermayer on the Politics and Business...
“Neuropharmacology: Psychedelics on the Brain” – Jim Harris, Rachel Zoeller, DPT, David W. Mcmillan, Ph.D., and Manesh Girn, Ph.D.
Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation...
Understanding ‘Spiritual Emergency’ in the Context of Psychedelics
atai Life Sciences Increases Loan in Principal by US$6m to Support...
Small Pharma Announces Engagement of Investor Relations Provider
Fear of Death Impacts Quality of Life-How Psychedelics Can Help
PT262 – Carlene MacMillan, M.D. – Set, Setting, and Systems: Adding...
Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research...
COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment...
Mindset Pharma Further Validates Lead Candidate, MSP-1014, as a Next Generation...
1
...
205
206
207
...
286
Page 206 of 286
